Kuros Biosciences Ltd. (CSBTF)
24.00
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
Kuros Biosciences Market Cap : 947.01M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 947.01M |
| September 17, 2026 | 947.01M |
| September 16, 2026 | 947.01M |
| September 15, 2026 | 947.01M |
| September 14, 2026 | 947.01M |
| September 11, 2026 | 947.01M |
| September 10, 2026 | 947.01M |
| September 09, 2026 | 947.01M |
| September 08, 2026 | 947.01M |
| September 04, 2026 | 868.09M |
| September 03, 2026 | 1.065B |
| September 02, 2026 | 1.065B |
| September 01, 2026 | 1.065B |
| August 31, 2026 | 1.065B |
| August 28, 2026 | 1.065B |
| August 27, 2026 | 1.065B |
| August 26, 2026 | 1.065B |
| August 25, 2026 | 1.065B |
| August 24, 2026 | 1.065B |
| August 21, 2026 | 1.065B |
| August 20, 2026 | 1.065B |
| August 19, 2026 | 1.065B |
| August 18, 2026 | 1.065B |
| August 17, 2026 | 1.065B |
| August 14, 2026 | 1.169B |
| Date | Value |
|---|---|
| August 13, 2026 | 1.169B |
| August 12, 2026 | 1.169B |
| August 11, 2026 | 1.169B |
| August 10, 2026 | 1.169B |
| August 07, 2026 | 1.160B |
| August 06, 2026 | 1.160B |
| August 05, 2026 | 1.001B |
| August 04, 2026 | 1.001B |
| August 03, 2026 | 1.001B |
| July 31, 2026 | 1.001B |
| July 30, 2026 | 1.001B |
| July 29, 2026 | 1.001B |
| July 28, 2026 | 1.001B |
| July 27, 2026 | 1.001B |
| July 24, 2026 | 1.001B |
| July 23, 2026 | 1.001B |
| July 22, 2026 | 1.001B |
| July 21, 2026 | 1.001B |
| July 20, 2026 | 1.001B |
| July 17, 2026 | 1.001B |
| July 16, 2026 | 1.001B |
| July 15, 2026 | 1.001B |
| July 14, 2026 | 1.001B |
| July 13, 2026 | 1.001B |
| July 10, 2026 | 1.001B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Molecular Partners AG | 161.26M |
| Basilea Pharmaceutica AG | 959.99M |
| Santhera Pharmaceuticals Holding AG | 265.06M |
| BeOne Medicines Ltd. | 36.55B |
| AC Immune SA | 239.59M |
Market Cap Related Metrics
| PE Ratio | 107.14 |
| PS Ratio | 5.494 |
| Price | 24.00 |
| Earnings Yield | 0.93% |
| Operating PE Ratio | 91.49 |
| Normalized PE Ratio | 107.14 |